DEBORAH J. NEFF - 01 Jun 2022 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
Director
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Deborah J. Neff
Issuer symbol
CTKB
Transactions as of
01 Jun 2022
Net transactions value
$0
Form type
4
Filing time
03 Jun 2022, 17:26:39 UTC
Next filing
16 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Stock Option (right to buy) Award $0 +47,013 $0.000000 47,013 01 Jun 2022 Common Stock 47,013 $9.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to the option vest monthly over three years from the vesting commencement date of June 1, 2022. The option becomes fully vested on June 1, 2025.